A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 2, 2000, Pages 204-212

  Yehualaeshet, Teshome ^a,b,c,d   O'Connor, Robert ^a,b,c,d   Begleiter, Asher ^a,b,c,d   Murphy Ullrich, Joanne E ^a,b,c,d   Silverstein, Roy ^a,b,c,d   Khalil, Nasreen ^a,b,c,d,e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^c University of Alabama at Birmingham   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0033844731     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.2.4089     Document Type: Article

References (34)

1. 1. Chandler, D. B., D. M. Hyde, and S. N. Giri. 1983. Morphometric estimates of infiltrative cellular changes during the development of Blm-induced pulmonary fibrosis in hamsters. Am. J. Pathol. 112:170-177.
2. 2. Kovacs, E. J., and J. Kelly. 1985. Secretion of macrophage-derived growth factors during acute lung injury induced by bleomycin. J. Leukoc. Biol. 37:1-14.
3. 3. Khalil, N., O. Bereznay, M. B. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
4. 4. Khalil, N., C. Whitman, L. Zuo, D. Danielpour, and A. H. Greenberg. 1993. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 92:1812-1818.
5. 5. Khalil, N., S. Corne, C. Whitman, and H. Yacyshyn. 1996. Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am. J. Respir. Cell Mol. Biol. 15:252-259.
6. 6. Yehualaeshet, T., R. O'Connor, J. Green-Johnson, S. Mai, R. Silverstein, J. E. Murphy-Ullrich, and N. Khalil. 1999. Activation of rat alveolar macrophage-derived L-TGF-β1 by plasmin requires interaction with TSF-1 and the TSP-1 cell surface receptor, CD36. Am. J. Pathol. 155:841-851.
7. 7. Maeda, A., K. Hiyama, H. Yamakido, S. Shioka, and M. Yamakido. 1996. Increased expression of platelet-derived growth factor A and insulin-growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest 109:780-786.
8. 8. Gharau-Kermani, M., B. McGarry, N. Lukacs, G. Huffnagle, R. W. Egan, and S. H. Phan. 1998. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 64:657-666.
9. 9. McCartney-Francis, N., D. Mizel, H. Wong, L. Wahl, amd S. Wahl. 1990. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocyctes. Growth Factor 4:27-35.
10. 10. Border, W. A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
11. 11. Khalil, N. 1999. TGF-β: from latent to active. Microb. Infect. I:1255-1263.
12. 12. Ribeiro, S. M., M. Poczatek, S. Schultz-Cherry, M. Villain, and J. E. Murphy-Ullrich. 1999. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J. Biol. Chem. 274:13586-13593.
13. 13. Munger, J. S., N. Huang, H. Kawakatsu, M. J. D. Griffiths, S. L. Dalton, J. J. Wu, J. F. Pittel, N. Kaminski, C. Garat, M. A. Mathay, D. B. Rifkin, and D. Sheppard. 1999. The integrin αvβ6 binds and activates latent-TGF-β1: mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328.
14. 14. Leung, L. L., L. Wei-Xing, J. L. McGregor, G. Albrecht, and R. J. Howard. 1993. CD36 peptides enhance or inhibit CD36 thrombospondin binding: a two-step process of ligand receptor interaction. J. Biol. Chem. 267:18244-18250.
15. 15. Begleiter, A., M. K. Leith, D. McClarty, S. Beenkin, G. J. Goldenberg, and J. A. Wright. 1998. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents. Cancer Res. 48:1727-1735.
16. 16. Westergren-Thorsson, G., J. Hernnas, B. Sarnstrand, A. Oldberg, D. Heinegard, and A. Malmstrom. 1993. Altered expression of small prosteoglycans, collagen and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92:632-637.
17. 17. Lazo, J. S., D. G. Hoyt, S. M. Sebti, and B. R. Pitt. 1990. Bleomycin: a pharmacological tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol. Ther. 47:347-358.
18. 18. Li, W. N., R. J. Howard, and L. L. K. Leung. 1993. Identification of CS-VTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36. J. Biol. Chem. 268:16179-16184.
19. 19. Magnetto, S., G. Brun-Bossio, C. Voland, J. Lecerf, J. Lawler, P. Delmas, R. Silverstein, and P. Clezardin. 1998. CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptoaxis on immobilized thrombospondin-1. Cell Biochem. Funct. 16:211-221.
20. 20. Brandes, M. E., U. E. Mai, K. Ohura, and S. M. Wahl. 1991. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J. Immunol. 147:1600-1606.
21. 21. Raugi, G. J., J. S. Olerud, and A. M. Gown. 1987. Thrombospondin in early wound tissue. Invest. Dermatol. 89:551-554.
22. 22. Reed, M. J., M. L. Sruela-Arispe, M. L. O'Brien, E. R. Truong, T. LaBel, P. Bernstein, and E. H. Sage. 1995. Expression of thrombospondins by endothelial cells: injury is correlated with TSP-1. Am. J. Pathol. 147:1068-1080.
23. 23. Dawson, D. W., S. Frieda, A. Pearce, R. Zhong, R. L. Silverstein, W. A. Frazier, and N. P. Bouck. 1997. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138:707-717.
24. 24. Daviet, L., and J. F. McGregor. 1997. Vascular biology of CD36: a role for this new adhesion molecule family in different disease states. Thromb. Haemost. 78:65-69.
25. 25. Ferroni, P., G. Spiziale, G. Ruvola, A. Giovannelli, F. M. Pulunelli, L. Lenti, P. Pignatelli, A. Criniti, E. Tonelli, B. Marino, and P. P. Gazzaniga. 1998. Platelet activation and cytokine production during hypothermic cardiopulmonary bypass: a possible correlation? Thromb. Haemost. 80:58-64.
26. 26. Giri, S. N., A. K. Sharma, D. M. Hyde, and J. S. Wilde. 1995. Amelioration of bleomycin-induced lung fibrosis by treatment with platelet activating factor receptor antogonist WEB 2086 in hamsters. Exp. Lung Res. 21:287-307.
27. 27. Schini-Kerth, V. B., S. Bassus, B. Fissethaler, C. M. Kirch-Maier, and R. Busse. 1997. Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor beta-1 and platelet derived growth factor AB. Circulation 96:3888-3896.
28. 28. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor I cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
29. 29. Shahzeidi, S., B. Sarnstrand, P. K. Jeffrey, R. J. McAnutty, and G. J. Laurent. 1991. Oral-n-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur. Respir. J. 4:845-852.
30. 30. Hyde, D. M., T. S. Henderson, S. N. Giri, N. K. Tyler, and M. Y. Stovall. 1988. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp. Lung Res. 14:687-704.
31. 31. Syer, S. N., G. Guriyeyalakshmi, and S. N. Giri. 1999. Effect of perfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J. Pharmacol. Exp. Ther. 289:211-218.
32. 32. Giri. S. N., D. M. Hyde, and M. A. Hollinger. 1993. Effects of antibody to transforming growth factor β on bleomycin-induced accumulation of lung collagen in mice. Thorax 48:959-966.
33. 33. Phan, S. H., M. Gharace-Kermani, F. Walber, and U. S. Ryan. 1991. Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin. J. Clin. Invest. 87:148-154.
34. 34. Tusznski, G. P., and R. F. Nicosia. 1996. The role of thrombospondin-1 in tumor progression and angiogenesis. BioEssays 18:71-75.